Abstract:
The WHO Global Oral Health Status Report (2022) estimated that oral diseases
affect close to 3.5 billion people worldwide, with 3 out of 4 people affected living in
middle-income countries. Aim: Study of antibacterial activity of aminohexafluorosilicates I-IV against
Porphyromonas gingivalis
Material and methods: Hexafluorosilicates (AHFS) I-IV were synthesized
according to previously described methods (Gelmboldt V., Shyshkin I.,Lytvynchuk I.,
2019–2022) .
